Unleashing the power of antimicrobial peptides

For the first time, peptides can now be used in medical devices to kill bacteria. Mimicking our own immune system, it is non toxic and safe.

How this platform technology
can revolutionise treatments

Amferia’s general patent now granted in Europe, the U.S. and China

Amferia’s innovation is protected by three strong patent families. The basic patent is already in force in Europe, the U.S. and China, and pending in several other countries. Ongoing R&D continues to generate new patent applications.

Read about all our patents >

United States patent sheet
Image showing Amferia product

Launching our first product for veterinary use

Read more>

Addressing antibiotic resistance the sustainable way

Read about the global threat and Amferia's vision>

After years of research, we suddenly realised how to combine our findings. 
It was a eureka moment.

Read about the Amferia story >